# Hamilton Lane INC: financial statements, quarterly

HLNE · Nasdaq · CIK 1433642 · [Financials](/sectors/financials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/hlne.md) · [Financials](/companies/hlne/financials.md) · [Filings](/companies/hlne/filings.md) · [Insiders](/companies/hlne/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hlne/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [127](/filings/0001433642-24-000116.md) | [125](/filings/0001433642-25-000010.md) | [177 d](/filings/0001433642-26-000019.md) | [197](/filings/0001433642-25-000072.md) | [150](/filings/0001433642-25-000117.md) | [168](/filings/0001433642-26-000007.md) | [198 d](/filings/0001433642-26-000019.md) | [176](/filings/0001433642-26-000042.md) | [191](/filings/0001433642-25-000117.md) | [199](/filings/0001433642-26-000007.md) | [194 d](/filings/0001433642-26-000019.md) | [275](/filings/0001433642-26-000042.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.9](/filings/0001433642-24-000116.md) | [15.8](/filings/0001433642-25-000010.md) | [20.4 d](/filings/0001433642-26-000019.md) | [19.7](/filings/0001433642-25-000072.md) | [1.2](/filings/0001433642-25-000117.md) | [12.7](/filings/0001433642-26-000007.md) | [15.0 d](/filings/0001433642-26-000019.md) | [18.4](/filings/0001433642-26-000042.md) | [14.0](/filings/0001433642-25-000117.md) | [27.3](/filings/0001433642-26-000007.md) | [15.6 d](/filings/0001433642-26-000019.md) | [25.1](/filings/0001433642-26-000042.md) |
| Net income | $m | [42.0](/filings/0001433642-24-000116.md) | [19.5](/filings/0001433642-25-000010.md) | [48.4 d](/filings/0001433642-26-000019.md) | [59.0](/filings/0001433642-25-000072.md) | [55.0](/filings/0001433642-25-000117.md) | [53.0](/filings/0001433642-26-000007.md) | [50.5 d](/filings/0001433642-26-000019.md) | [53.7](/filings/0001433642-26-000042.md) | [70.9](/filings/0001433642-25-000117.md) | [58.4](/filings/0001433642-26-000007.md) | [66.2 d](/filings/0001433642-26-000019.md) | [80.5](/filings/0001433642-26-000042.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [1,359](/filings/0001433642-23-000099.md) | [1,209](/filings/0001433642-24-000010.md) | [1,271](/filings/0001433642-25-000052.md) | [1,372](/filings/0001433642-24-000085.md) | [1,424](/filings/0001433642-24-000116.md) | [1,591](/filings/0001433642-25-000010.md) | [1,690](/filings/0001433642-26-000019.md) | [1,802](/filings/0001433642-25-000072.md) | [1,980](/filings/0001433642-25-000117.md) | [2,171](/filings/0001433642-26-000007.md) | [2,305](/filings/0001433642-26-000042.md) | [2,539](/filings/0001433642-26-000042.md) |
| Total liabilities | $m | [577](/filings/0001433642-23-000099.md) | [585](/filings/0001433642-24-000010.md) | [595](/filings/0001433642-25-000052.md) | [635](/filings/0001433642-24-000085.md) | [622](/filings/0001433642-24-000116.md) | [729](/filings/0001433642-25-000010.md) | [766](/filings/0001433642-26-000019.md) | [807](/filings/0001433642-25-000072.md) | [822](/filings/0001433642-25-000117.md) | [845](/filings/0001433642-26-000007.md) | [838](/filings/0001433642-26-000042.md) | [847](/filings/0001433642-26-000042.md) |
| Long-term debt | $m | [197](/filings/0001433642-23-000099.md) | [197](/filings/0001433642-24-000010.md) | [196](/filings/0001433642-25-000052.md) | [196](/filings/0001433642-24-000085.md) | [195](/filings/0001433642-24-000116.md) | [292](/filings/0001433642-25-000010.md) | [290](/filings/0001433642-26-000019.md) | [289](/filings/0001433642-25-000072.md) | [286](/filings/0001433642-25-000117.md) | [280](/filings/0001433642-26-000007.md) | [278](/filings/0001433642-26-000042.md) | [274](/filings/0001433642-26-000042.md) |
| Shareholders' equity | $m | [463](/filings/0001433642-23-000099.md) | [468](/filings/0001433642-24-000010.md) | [525](/filings/0001433642-25-000052.md) | [566](/filings/0001433642-24-000085.md) | [607](/filings/0001433642-24-000116.md) | [649](/filings/0001433642-25-000010.md) | [717](/filings/0001433642-26-000019.md) | [759](/filings/0001433642-25-000072.md) | [826](/filings/0001433642-25-000117.md) | [877](/filings/0001433642-26-000007.md) | [915](/filings/0001433642-26-000042.md) | [939](/filings/0001433642-26-000042.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [77.6 d](/filings/0001433642-24-000116.md) | [(36.4) d](/filings/0001433642-25-000010.md) | [21.7 d](/filings/0001433642-26-000019.md) | [79.7](/filings/0001433642-25-000072.md) | [117 d](/filings/0001433642-25-000117.md) | [64.4 d](/filings/0001433642-26-000007.md) | [39.3 d](/filings/0001433642-26-000019.md) | [129](/filings/0001433642-26-000042.md) | [119 d](/filings/0001433642-25-000117.md) | [74.1 d](/filings/0001433642-26-000007.md) | [103 d](/filings/0001433642-26-000019.md) | [77.2](/filings/0001433642-26-000042.md) |
| Capital expenditure | $m | [2.9 d](/filings/0001433642-24-000116.md) | [3.2 d](/filings/0001433642-25-000010.md) | [1.6 d](/filings/0001433642-26-000019.md) | [1.5](/filings/0001433642-25-000072.md) | [1.6 d](/filings/0001433642-25-000117.md) | [5.6 d](/filings/0001433642-26-000007.md) | [3.4 d](/filings/0001433642-26-000019.md) | [1.3](/filings/0001433642-26-000042.md) | [1.1 d](/filings/0001433642-25-000117.md) | [1.7 d](/filings/0001433642-26-000007.md) | [1.7 d](/filings/0001433642-26-000019.md) | [1.8](/filings/0001433642-26-000042.md) |
| Dividends paid | $m | [16.8 d](/filings/0001433642-24-000116.md) | [16.8 d](/filings/0001433642-25-000010.md) | [16.8 d](/filings/0001433642-26-000019.md) | [17.6](/filings/0001433642-25-000072.md) | [19.5 d](/filings/0001433642-25-000117.md) | [19.5 d](/filings/0001433642-26-000007.md) | [19.5 d](/filings/0001433642-26-000019.md) | [20.2](/filings/0001433642-26-000042.md) | [22.3 d](/filings/0001433642-25-000117.md) | [22.6 d](/filings/0001433642-26-000007.md) | [22.6 d](/filings/0001433642-26-000019.md) | [22.5](/filings/0001433642-26-000042.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.